China approves Sinopharm’s COVID-19 vaccine, prepares to inoculate all citizens with free shots

China granted authorization to Sinopharm’s COVID-19 vaccine Dec. 31, approving its first state-developed COVID-19 vaccine for use in the general public, CNN reported.

Advertisement

The approval comes one day after the drugmaker said its vaccine is 79.34 percent effective in preventing COVID-19, citing interim analysis of phase 3 clinical trials.

Chinese citizens will be provided free vaccinations, Zeng Yixin, vice minister of China’s National Health Commission, said during a Dec. 31 news conference. The country is seeking to inoculate 50 million people with domestically developed COVID-19 vaccines before February’s Lunar New Year festivities, according to CNN.

More articles on pharmacy:
UK approves AstraZeneca’s COVID-19 vaccine
340B discounts apply to contract pharmacies, HHS clarifies
U of Missouri settles suit against former pharmacy professor accused of selling student research

 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.